Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2025-04-30' to '2025-05-13'.SummaryDifference1%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated to reflect a new version, v2.15.2, and the previous version, v2.15.0, has been removed. Additionally, a date of April 30, 2025, has been added.SummaryDifference1.0%
- Check38 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check45 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 7, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.6%
- Check75 days agoChange DetectedThe date has been updated from January 27, 2025, to March 7, 2025.SummaryDifference0.6%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.